Strahlentherapie nach brusterhaltender Operation beim Mammakarzinom

J. Dunst,R. Baumann,P. Jiang,Constanze Walldorf,D. Bauerschlag

DOI: https://doi.org/10.1007/s00129-017-4153-9

2017-10-20

Der Gynäkologe

Abstract:

What problem does this paper attempt to address?

Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis

Greta M. Joy,Omri A. Arbiv,Carmen K. Wong,Stacey D. Lok,Nicola A. Adderley,Krzysztof M. Dobosz,Kerri A. Johannson,Christopher J. Ryerson

DOI: https://doi.org/10.1183/16000617.0210-2022

IF: 7.5

2023-03-08

European Respiratory Review

Abstract:Introduction Interstitial lung disease (ILD) is a frequent manifestation of connective tissue disease (CTD) with substantial variability in prevalence and outcomes reported across CTD subtypes. This systematic review summarises the prevalence, risk factors and ILD patterns on chest computed tomography of CTD-ILD. Methods A comprehensive search was performed in Medline and Embase to identify eligible studies. Meta-analyses were completed using a random effects model to determine the pooled prevalence of CTD-ILD and ILD patterns. Results 11 582 unique citations were identified with 237 articles included. Pooled prevalence of ILD was 11% in rheumatoid arthritis (95% CI 7–15%), 47% in systemic sclerosis (44–50%), 41% in idiopathic inflammatory myositis (33–50%), 17% in primary Sjögren's syndrome (12–21%), 56% in mixed connective tissue disease (39–72%) and 6% in systemic lupus erythematosus (3–10%). Usual interstitial pneumonia was the most prevalent ILD pattern in rheumatoid arthritis (pooled prevalence of 46%), while nonspecific interstitial pneumonia was the most common ILD pattern in all other CTD subtypes (pooled prevalence range 27–76%). Across all CTDs with available data, positive serology and higher inflammatory markers were risk factors for development of ILD. Discussion We identified substantial variability in ILD across CTD subtypes suggesting that CTD-ILD is too heterogenous to be considered a single entity.

respiratory system
Clinical manifestations of connective tissue diseases complicated with interstitial lung disease:an analysis of 90 cases

SUN Yue,LI Haichao

2009-01-01

Abstract:Objective To strengthen the understanding and knowledge of connective tissue diseases(CTD) complicated with interstitial lung disease(ILD) by reviewing the clinical manifestations,blood gas analysis,and pulmonary function data of patients.Methods The clinical manifestations,blood gas analysis,and pulmonary function data of 90 patients with CTD-ILD,who were treated from January 1997 to December 2007 in the in-patient department,were retrospectively analyzed.Results Thirty-nine patients were male and 51 were female,with an age range from 11 to 87 years old(average [62±15] years).The CTD included 13 cases with rheumatoid arthritis(RA),2 with systemic sclerosis(SSc),9 with dermatomyositis(DM)/polymyositis(PM),8 with sjogren syndrome(SS),6 with systemic lupus erythematosus(SLE),9 with overlap syndrome(OS),10 with undifferentiated connectived tissue disease(UD-CTD),and 33 with antineutrophil cytoplasmic antibody(ANCA) associated systemic vasculitis(AASV).The incidences of respiratory symptoms,such as cough,dyspnea,and haemoptysis,were higher than those of general symptoms,such as fever,fatigue,arthralgia and skin lesion.Among the 81 cases who received blood gas analysis,31 had hypoxemia,16 had respiratory failure type Ⅰ,and 2 had respiratory failure type Ⅱ.Among 45 cases who received pulmonary function test,25 had restrictive,2 had obstructive and 4 had mixed ventilation defect.Reduced diffusing capacity(DLCO decreased) was observed in 39 cases.Conclusion Patients with CTD-ILD have higher incidences of respiratory symptoms and lower incidences of general symptoms.The clinical manifestations of CTD may not be prominent when there are interstitial lung diseases;therefore the possibility of ILD second to CTD should be considered in these patients.The characteristics of pulmonary function of patients with CTD-ILD are mainly restrictive ventilation defect and reduced diffusing capacity.When combined with obstructive ventilation defects,the possibility of bronchiolitis should be considered.
E012 Burden and risk factors for cardiovascular involvement in connective tissue disease

Kapil K Garg,Swetha Sampath,Amirah Erinjogunola,Brian Ting,Hayder Noori,Gouri M Koduri

DOI: https://doi.org/10.1093/rheumatology/keae163.241

2024-04-01

Rheumatology

Abstract:Abstract Background/Aims Connective tissue diseases (CTD) are associated with several cardiovascular manifestations. Cardiovascular diseases (CVD) are significant cause of morbidity and premature death. The pathogenesis of CVD in CTD patients is incompletely understood and likely multifactorial. Traditional risk factors for atherosclerosis are common among patients with CTD as well as metabolic syndrome. Furthermore, diabetes, dyslipidaemia, hypertension, and obesity may all be exacerbated by connective tissue disease itself or treatment with glucocorticoids. The aim of this study was to assess the burden of CVD and the risk factors for the development of cardiovascular disease in patients with CTD. Methods This was a retrospective study from a single centre. We reviewed clinical records of CTD patients as determined by treating rheumatologist. This CTD cohort included patients with systemic lupus erythematosus (SLE), myositis, systemic sclerosis, Sjogren’s syndrome, mixed and undifferentiated connective tissue diseases. Data on demographic, clinical, laboratory parameters, cardiac investigations, treatment and outcome were collected from electronic patient records. CVD and traditional risk factors were defined using standard criteria. Results A total of 298 patients with CTD were included in the analysis. Mean age of the cohort was 61±17.7 years and majority were females (n = 240, 80.5%). Of the 298 patients, 64 had CVD (21.5%). Most common CVD was ischaemic heart disease (17 patients) followed by hypertension (12), arrhythmia (9), pulmonary arterial hypertension (7), valvular diseases (5), pericardial disease (3), cardiomyopathy (3), myocarditis (2), thromboembolism (3), aortic dissection (2) and coronary spasm (1). Patient with CTD who had CVD were older (72.5±12.2 years) compared to CTD patients who did not develop CVD (non-CVD group, 57.7±17.6 years). The duration of CTD was shorter in patients with CVD (88.9±41.7 months), compared to 106±84.3 months in non-CVD group. The risk factors such as smoking, diabetes and dyslipidaemia was higher in the CVD group. Comparing CVD vs non-CVD patients respectively, systolic BP (147.1±23.0 vs 133.6±18.3mmHg), diastolic BP (83.2 ± 16.3 vs 78.2 ± 11.2mmHg) and serum uric acid (321.8±97.4 vs 292±83.9mg/dL) values were higher and statistically significant (p < 0.05) in CVD group. Patients with CVD had longer exposure to steroids (50%) compared to non-CVD patients (31.6%). They required high dose steroids (9.4% vs 5.6% in non-CVD patients). Current and previous DMARD use was also higher in patients who had CVD (51.6% vs 44.9%). Conclusion This study has demonstrated high burden of cardiovascular disease in CTD patients. Traditional risk factors were more prevalent in the CVD group. DMARD’s and steroid use was also higher in the CVD group. Screening for cardiovascular diseases and disease control in CTD patients is paramount for better outcomes. Further analysis will be carried out for risk factors and relevant outcomes. Disclosure K.K. Garg: None. S. Sampath: None. A. Erinjogunola: None. B. Ting: None. H. Noori: None. G.M. Koduri: None.

rheumatology
Analysis of Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 161 Patients: A Retrospective Study

Mingjie Lu,Ling Gong,Chengyan Huang,Meng Ye,Hongping Wang,Yi Liu,Daishun Liu

DOI: https://doi.org/10.2147/IJGM.S391146

IF: 2.145

2022-12-16

International Journal of General Medicine

Abstract:Mingjie Lu, 1, &ast Ling Gong, 1, &ast Chengyan Huang, 1 Meng Ye, 2 Hongping Wang, 3 Yi Liu, 3 Daishun Liu 3 1 Department of Respiratory Medicine, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, 563000, People's Republic of China; 2 Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou, 563000, People's Republic of China; 3 Zunyi Medical University, Zunyi, Guizhou, 563000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Daishun Liu, Zunyi Medical University, No. 6 Xuefu West Road, Xinpu New District, Zunyi, Guizhou, 563000, People's Republic of China, Email Objective: This study was conducted to retrospectively analyze the clinical characteristics of CTD-ILD patients to provide strategies for clinical management. Methods: This study collected and analyzed the clinical data and relevant examination results of 161 patients diagnosed with CTD-ILD between 01 January 2018 and 01 January 2021. Results: A total of 161 CTD-ILD patients, 74.53% were females and 25.47% were males, 32.92% were elderly and 67.08% were non-elderly. The main clinical symptoms of CTD-ILD patients were cough (44.72%), decreased activity tolerance (40.37%). RA-ILD was the most common one in the non-elderly and the elderly CTD-ILD patients (48.15% and 50.94%, respectively). Compared with non-elderly, elderly patients with CTD-ILD had a longer duration of CTD ( p =0.04). However, fatigue ( p =0.005), activity tolerance ( p =0.029), the incidence of pulmonary diffusion dysfunction ( p =0.047), and systemic immunoinflammatory index (SII, p =0.014) (platelet × NLR) were all decreased. The standard deviation of red blood cell distribution width (RDW) ( p =0.024) and immunoglobulin (IgA) ( p =0.033) was significantly increased. The smoking index was significantly higher in men than in women with CTD-ILD ( p =0.000), but symptoms of reduced activity tolerance were less pronounced than in women ( p < 0.05). Elderly CTD-ILD patients ( p =0.003) and women from non-elderly patients were prone to lower hemoglobin ( p =0.000). Among the elderly, the lymphocyte ratio was more significantly elevated in female CTD-ILD patients than in males ( p =0.018). In contrast, neutrophil to lymphocyte ratio (NLR) and SII were lower in female ( p =0.038) than in male CTD-ILD patients ( p =0.043). Conclusion: CTD-ILD mainly affects non-elderly and women. Age may not be involved with decreased activity tolerance and increased lung function impairment in CTD-ILD patients. However, the elderly patients with CTD-ILD, especially the elderly female patients with low inflammation levels and high immune disorders, have a poor prognosis. Keywords: CTD-ILD, rheumatoid arthritis, pulmonary functions, clinical characteristics Connective tissue-associated interstitial lung disease (CTD-ILD) is a disease that results from the association of lungs with connective tissue diseases such as systemic lupus erythematosus (SLE), polymyositis (PM)/dermatomyositis (DM), systemic sclerosis (SSc), rheumatoid arthritis (RA), and sjögren's syndrome (SS), etc. CTD-ILD patients have a significantly lower 10-year survival time and higher risk of death, and an insidious and heterogeneous onset compared to the CTD patients alone. 1–4 The average survival time for CTD-ILD patients is only 6.5 years, as reported in the literature. 5,6 Pulmonary involvement varies among patients with CTD-ILD, with up to 80% involvement in RA. 7–9 SSc-ILD has a prevalence of 30–90% 10,11 with a 10-year mortality rate of up to 40%. 12,13 In addition, the prevalence of CTD-ILD in the elderly is increasing with age, progressive reduction in chest wall compliance, muscle strength, disease-induced inflammation, autophagy, mitochondrial dysfunction, and decreased lung function, among many other reasons. However, the current prevalence and clinical features of CTD-ILD in the elderly are unknown. This leads to a more challenging diagnosis and treatment of CTD-ILD in the elderly, thus burdening global health resources. Therefore, the aim of this study is to retrospectively analyze and summarize the clinical characteristics of 161 patients with CTD-ILD as well as to analyze and compare the characteristics of CTD-ILD in non-elderly and elderly patients, and CTD-ILD in different genders. This study may provide important evidence and strategies for clinical diagnosis -Abstract Truncated-

medicine, general & internal
Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE

Wenli Jiang,Wenhui Jia,Chunling Dong

DOI: https://doi.org/10.1186/s12959-024-00599-3

2024-04-05

Thrombosis Journal

Abstract:As an autoimmune disease, the persistent systemic inflammatory response associated with connective tissue disease (CTD) is involved in the development of venous thromboembolism (VTE). However, clinical data showed that the risk of VTE in patients differed between subtypes of CTD, suggesting that different subtypes may have independent mechanisms to promote the development of VTE, but the specific mechanism lacks sufficient research at present. The development of pulmonary fibrosis also contributes to the development of VTE, and therefore, patients with CTD-associated interstitial lung disease (CTD-ILD) may be at higher risk of VTE than patients with CTD alone or patients with ILD alone. In addition, the activation of the coagulation cascade response will drive further progression of the patient's pre-existing pulmonary fibrosis, which will continue to increase the patient's risk of VTE and adversely affect prognosis. Currently, the treatment for CTD-ILD is mainly immunosuppressive and antirheumatic therapy, such as the use of glucocorticoids and janus kinase-inhibitors (JAKis), but, paradoxically, these drugs are also involved in the formation of patients' coagulation tendency, making the clinical treatment of CTD-ILD patients with a higher risk of developing VTE challenging. In this article, we review the potential risk factors and related mechanisms for the development of VTE in CTD-ILD patients to provide a reference for clinical treatment and prevention.

peripheral vascular disease,hematology
The impact of hospitalization on mortality in patients with connective tissue disease-associated interstitial lung disease: a medical records review study

Anna Korogodina,Navneet Kaur,Xianhong Xie,Adhya Mehta,Krystal L. Cleven,Bibi Ayesha,Anand Kumthekar

DOI: https://doi.org/10.1186/s42358-023-00343-x

2024-01-02

Advances in Rheumatology

Abstract:Abstract Background Interstitial lung disease (ILD) remains one of the most important causes of morbidity and mortality in patients with Connective Tissue Diseases (CTD). This study evaluated the impact of hospitalization on mortality in an ethnically and racially diverse cohort of CTD-ILD patients. Methods We conducted a medical records review study at Montefiore Medical Center, Bronx, NY. We included 96 patients and collected data on demographic characteristics, reasons for hospitalization, length of stay, immunosuppressant therapy use, and mortality. We stratified our patients into two cohorts: hospitalized and non-hospitalized. The hospitalized cohort was further subdivided into cardiopulmonary and non-cardiopulmonary admissions. Two-sample tests or Wilcoxon’s rank sum tests for continuous variables and Chi-square or Fisher’s exact tests for categorical variables were used for analyses as deemed appropriate. Results We identified 213 patients with CTD-ILD. Out of them, 96 patients met the study’s inclusion criteria. The majority of patients were females (79%), and self-identified as Hispanic (54%) and Black (40%). The most common CTDs were rheumatoid arthritis (RA) (29%), inflammatory myositis (22%), and systemic sclerosis (15%). The majority (76%) of patients required at least one hospitalization. In the non-hospitalized group, no deaths were observed, however we noted significant increase of mortality risk in hospitalized group ( p = 0.02). We also observed that prolonged hospital stay (> 7 days) as well as older age and male sex were associated with increased mortality. Conclusions Prolonged (> 7 days) hospital stay and hospitalization for cardiopulmonary causes, as well as older age and male sex were associated with an increased mortality risk in our cohort of CTD-ILD patients.

rheumatology
Synergism of X irradiation and radiographic contrast medium.

D. Carr,A. Walker,A. Tannahill,R. G. White

DOI: https://doi.org/10.1259/0007-1285-54-646-919

1981-10-01

British Journal of Radiology

Abstract:Radiographic contrast media (RCM) are more toxic in animals with endotoxaemia (Slivka et al., 1978). External abdominal X irradiation releases endotoxin from gut (Taketa, 1962). We have investigated the effect of large doses of abdominal X irradiation and intravenous meglumine ioglycamate in rabbits to determine whether or not the effects are additive. Seven groups of white endotoxin-negative New Zealand rabbits (weight 2.1 to 2.9 kg) were studied (Groups A–G). The groups were treated with various combinations of external abdominal X irradiation and intravenous meglumine ioglycamate (Table I). The radiation was administered with a Dynaray 4, 4 MeV linear accelerator (Radiation Dynamics Ltd.), FSD 100 cm, field size 15×10 cm, dose measured at depth of 10 cm from skin surface. Meglumine ioglycamate was administered intravenously via an ear vein at a rate of 1 g/min. The experiments on Groups B and D were repeated, substituting 125I-labelled meglumine ioglycamate for ordinary meglumine ioglycamate. All the a...
Characteristics and Survival of Connective Tissue Disease Associated Pulmonary Arterial Hypertension Patients with and Without Interstitial Lung Disease

Yanjie Hao,Lan Wang,Xin Jiang,Qinhua Zhao,Wei Ma,Yong Wang,Lan Gao,Zhicheng Jing,ZhuoLi Zhang

DOI: https://doi.org/10.3760/cma.j.issn.1007-7480.2017.05.006

2017-01-01

Abstract:Objective To explore the characteristics and survival of connective tissue disease (CTD) patients with both of pulmonary arterial hypertension (PAH) arnd interstitial lung disease (ILD),and to compare with CTD patients with isolated PAH.Methods All adult CTD patients who visited one of the three referral centers in China with a diagnosis of PAH confirmed by right heart catheterization from July 2006 to May 2011 were enrolled.They were then divided into two groups (ILD with and without-ILD group) based on chest CT and then the comparison of baseline characteristics and survival at the endpoint of follow up were made between the two groups.T test,Mann-Whitney U test,x2 test,Kaplan-Meier survival analysis and Cox regression analysis were used for statistical analyses.Results One hundred and twenty-six patients were recruited into the study.Patients with ILD (n=27) were older than those without ILD (n=99).Lung function results including FVC [(75±18)％ vs (83±13)％,t=2.212,P=0.037] and DLCO [(54±22)％ vs (68±20)％,t=2.392,P=0.019] in ILD group were significantly wose than those without-ILD group.Although some important hemodynamic parameters such as mean pulmonary arterial pressure and pulmonary vascular resistance were better in the ILD group than the without-ILD group,Kaplan-Meier analysis showed that the short term survival of ILD group was significantly worse than that of the without-ILD group (72.7％ versus 94.7％ at 1 year and 63.6％ versus 81.1％ at 3 year,P=0.047).In ILD group,Cox regression analysis showed that SvO2 was the only independent factor for the short term survival [HR=0.19,95％CI (0.04,0.83),P=0.027],and Kaplan-Meier analysis showed patients with SvO2＜60％ had significantly lower short term survival than patients with SvO2 ≥60％ (1 and 2 year survival were 60.0％ and 40.0％ versus 92.9％ and 77.4％ respectively,P=0.002).Conclusion Patients with both PAH and ILD is a special subtype in CTD.Although with the superiority of hemodynamics,these patients have significantly worse survival than CTD patients with isolated PAH.Low SvO2 is the independent risk factor for the short term mortality in patients of CTD complicated by both PAH and ILD.More attention should be paid to these patients and the management strategy should be investigated further.
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease

Erica Mulcaire-Jones,Janelle Vu Pugashetti,Justin M. Oldham,Dinesh Khanna

DOI: https://doi.org/10.1055/s-0044-1786155

2024-05-15

Seminars in Respiratory and Critical Care Medicine

Abstract:Connective tissue diseases (CTD) comprise a group of autoimmune diseases that can affect multiple organs in the body including the lungs. The most common form of pulmonary involvement is interstitial lung disease (ILD). CTD-associated ILD (CTD-ILD) can take one of several courses including nonprogressive, chronically progressive, or rapidly progressive. Chronically and rapidly progressive patterns are associated with increased mortality. Limited randomized controlled trial data are available for treatment of CTD-ILD, with most data coming from systemic sclerosis-related ILD. The current first-line treatment for all CTD-ILD is immunosuppression with consideration of antifibrotics, stem cell transplant, and lung transplant in progressive disease. In this article, we review data for ILD treatment options in systemic sclerosis, rheumatoid arthritis, myositis, and primary Sjögren's syndrome-related ILDs. Article published online: 13 May 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

respiratory system,critical care medicine
Comparative analysis of connective tissue disease–associated interstitial lung disease and interstitial pneumonia with autoimmune features

Mengxue Tian,Wenhan Huang,Feifeng Ren,Lei Luo,Jun Zhou,Dongmei Huang,Lin Tang

DOI: https://doi.org/10.1007/s10067-019-04836-3

2019-11-22

Clinical Rheumatology

Abstract:ObjectiveThis retrospective clinical study aimed to examine the similarities and differences between connective tissue disease–associated interstitial lung disease (CTD-ILD) and interstitial pneumonia with autoimmune features (IPAF) and to identify the influencing factors of CTD-ILD, with a goal of early detection and active treatment of the disease.MethodsWe conducted a retrospective study of 480 patients: 412 with CTD-ILD and 68 with IPAF. Demographic features, clinical characteristics, laboratory indicators, and chest high-resolution computed tomography (HRCT) imaging data were analyzed.ResultsCompared with the IPAF group, the CTD-ILD group contained more women, and the incidences of joint pain, dry mouth/dry eyes, and Raynaud’s phenomenon were higher; erythrocyte sedimentation rate (ESR) and D-dimer levels were higher; red blood cell (RBC) and hemoglobin (Hb) levels were lower; a high rheumatoid factor (RF) titer (> 2 times the normal upper limit) was observed, and anti-cyclic citrullinated peptide antibody (anti-CCP), anti-keratin antibody (AKA), antinuclear antibody (ANA), and anti-melanoma differentiation-associated gene 5 antibody (anti-MDA5) levels were higher. Compared with CTD-ILD patients, IPAF patients were more likely to present initially with respiratory symptoms, with higher rates of fever, cough and expectoration, dyspnea, and Velcro crackles; anti-Ro52 titers were higher; incidences of honeycombing opacity, reticulate opacity, patchy opacity, and pleural thickening were greater. Female sex, a high RF titer (> 2 times the normal upper limit), anti-CCP positivity, ANA positivity, and anti-MDA5 positivity were risk factors for CTD-ILD when the odds ratios were adjusted.ConclusionCTD-ILD and IPAF patients differed in demographic features, clinical characteristics, laboratory indicators, and chest HRCT imaging data. Female sex, a high RF titer (> 2 times the normal upper limit), anti-CCP positivity, ANA positivity, and anti-MDA5 positivity were risk factors for CTD-ILD.Key Points• This retrospective clinical study comprehensively compared the demographic features, clinical characteristics, laboratory indicators, and chest HRCT imaging data of CTD-ILD and IPAF patients.• The evidence suggested that female sex, a high RF titer, anti-CCP positivity, ANA positivity, and anti-MDA5 positivity were risk factors for CTD-ILD.

rheumatology
Microvascular alterations of the ocular surface and retina in connective tissue disease-related interstitial lung disease

Li-Ming Chen,Min Kang,Jun-Yi Wang,San-Hua Xu,Cheng Chen,Hong Wei,Qian Ling,Liang-Qi He,Jie Zou,Yi-Xin Wang,Xu Chen,Ping Ying,Hui Huang,Yi Shao,Rui Wu

DOI: https://doi.org/10.18240/ijo.2024.10.14

2024-10-18

Abstract:Aim: To examine the disparities in macular retinal vascular density between individuals with connective tissue disease-related interstitial lung disease (CTD-ILD) and healthy controls (HCs) by optical coherence tomography angiography (OCTA) and to investigate the changes in microvascular density in abnormal eyes. Methods: For a retrospective case-control study, a total of 16 patients (32 eyes) diagnosed with CTD-ILD were selected as the ILD group. The 16 healthy volunteers with 32 eyes, matched in terms of age and sex with the patients, were recruited as control group. The macular retina's superficial retinal layer (SRL) and deep retinal layer (DRL) were examined and scanned using OCTA in each individual eye. The densities of retinal microvascular (MIR), macrovascular (MAR), and total microvascular (TMI) were calculated and compared. Changes in retinal vascular density in the macular region were analyzed using three different segmentation methods: central annuli segmentation method (C1-C6), hemispheric segmentation method [uperior right (SR), superior left (SL), inferior left (IL), and inferior right (IR)], and Early Treatment Diabetic Retinopathy Study (ETDRS) methods [superior (S), inferior (I), left (L), and right (R)]. The data were analyzed using Version 9.0 of GraphPad prism and Pearson analysis. Results: The OCTA data demonstrated a statistically significant difference (P<0.05) in macular retinal microvessel density between the two groups. Specifically, in the SRL and DRL analyses, the ILD group exhibited significantly lower surface density of MIR and TMI compared to the HCs group (P<0.05). Furthermore, using the hemispheric segmentation method, the ILD group showed notable reductions in SL, SR, and IL in the superficial retina (P<0.05), as well as marked decreases in SL and IR in the deep retina (P<0.05). Similarly, when employing the ETDRS method, the ILD group displayed substantial drops in superficial retinal S and I (P<0.05), along with notable reductions in deep retinal L, I, and R (P<0.05). In the central annuli segmentation method, the ILD group exhibited a significant decrease in the superficial retinal C2-4 region (P<0.05), whereas the deep retina showed a notable reduction in the C3-5 region (P<0.05). Additionally, there was an observed higher positive likelihood ratio in the superficial SR region and deep MIR. Furthermore, there was a negative correlation between conjunctival vascular density and both deep and superficial retinal TMI (P<0.001). Conclusion: Patients with CTD-ILD exhibits a significantly higher conjunctival vascular density compared to the HCs group. Conversely, their fundus retinal microvascular density is significantly lower. Furthermore, CTD-ILD patients display notably lower superficial and deep retinal vascular density in comparison to the HCs group. The inverse correlation between conjunctival vascular density and both superficial and deep retinal TMI suggests that detecting subtle changes in ocular microcirculation could potentially serve as an early diagnostic indicator for connective tissue diseases, thereby enhancing disease management.
Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study

Huaxia Yang,Zhuoran Yao,Xiaoxiang Zhou,Zhongxing Bing,Lei Cao,Zhili Cao,Shanqing Li,Xuan Zhang,Yan Zhao,Xiaofeng Zeng,Fengchun Zhang,Naixin Liang

DOI: https://doi.org/10.21037/atm-20-1072

IF: 3.616

2020-11-01

Annals of Translational Medicine

Abstract:BACKGROUND: Connective tissue diseases (CTDs) are a group of special commodities in lung cancer (LC). This study aimed to analyze the survival and prognostic factors of LC patients with preexisting CTDs.METHODS: A total of 84 LC patients with preexisting CTDs that presented at Peking Union Medical College Hospital (PUMCH) were retrospectively recruited in this study between January 2000 and June 2017. Patient survival was compared using the Kaplan-Meier method. Univariate and multivariate Cox proportional hazard models were used to assess prognostic variables.RESULTS: Of the 84 LC patients, 36 (41.8%) had underlying rheumatoid arthritis (RA), 20 (23.8%) had idiopathic inflammatory myopathy (IIM), 18 (21.4%) had Sjögren syndrome (SS), 6 (7.1%) had systemic sclerosis (SSc), and 4 (4.8%) had systemic lupus erythematosus (SLE). The median overall survival (OS) was 21 months (IQR, 8-72 months), and the 1-, 3-, and 5-year survival rates were 61.3%, 36.7%, and 29.5%, respectively. The survival rates between different CTD subgroups, histopathologies, and disease stages were significantly different (P<0.05). Multivariate analysis showed that the independent prognostic factors for OS were IIM [hazard ratio (HR), 3.61; 95% confidence intervals (CI), 1.69-8.21; P=0.002], SS (HR, 2.72; 95% CI, 1.01-7.33; P=0.048), and radical resection (HR, 0.11; 95% CI, 0.04-0.35; P<0.001).CONCLUSIONS: Different CTD subtypes and the radical resection of LC are closely related to patient prognosis. This indicates a need for both identifications of CTD types and active treatment strategies for LC.

oncology,medicine, research & experimental
Lung imaging patterns in connective tissue disease–associated interstitial lung disease impact prognosis and immunosuppression response

Boyang Zheng,Daniel-Costin Marinescu,Cameron J Hague,Nestor L Muller,Darra Murphy,Andrew Churg,Joanne L Wright,Amna Al-Arnawoot,Ana-Maria Bilawich,Patrick Bourgouin,Gerard Cox,Celine Durand,Tracy Elliot,Jennifer Ellis,Jolene H Fisher,Derek Fladeland,Amanda Grant-Orser,Gillian C Goobie,Zachary Guenther,Ehsan Haider,Nathan Hambly,James Huynh,Kerri A Johannson,Geoffrey Karjala,Nasreen Khalil,Martin Kolb,Jonathon Leipsic,Stacey D Lok,Sarah MacIsaac,Micheal McInnis,Helene Manganas,Veronica Marcoux,John Mayo,Julie Morisset,Ciaran Scallan,Tony Sedlic,Shane Shapera,Kelly Sun,Victoria Tan,Alyson W Wong,Christopher J Ryerson

DOI: https://doi.org/10.1093/rheumatology/keae076

2024-02-09

Rheumatology

Abstract:Abstract Objectives Interstitial lung disease (ILD) in CTDs has highly variable morphology. We aimed to identify imaging features and their impact on ILD progression, mortality, and immunosuppression response. Methods Patients with CTD-ILD had high-resolution chest CT (HRCT) reviewed by expert radiologists blinded to clinical data for overall imaging pattern [usual interstitial pneumonia (UIP); non-specific interstitial pneumonia (NSIP); organizing pneumonia (OP); fibrotic hypersensitivity pneumonitis (fHP); and other]. Transplant-free survival and change in percent-predicted forced vital capacity (FVC) were compared using Cox and linear mixed-effects models adjusted for age, sex, smoking, and baseline FVC. FVC decline after immunosuppression was compared with pre-treatment. Results Among 645 CTD-ILD patients, the most frequent CTDs were SSc (n = 215), RA (n = 127), and inflammatory myopathies (n = 100). NSIP was the most common pattern (54%), followed by UIP (20%), fHP (9%), and OP (5%). Compared with the case for patients with UIP, FVC decline was slower in patients with NSIP (by 1.1%/year, 95% CI 0.2, 1.9) or OP (by 3.5%/year, 95% CI 2.0, 4.9), and mortality was lower in patients with NSIP [hazard ratio (HR) 0.65, 95% CI 0.45, 0.93] or OP (HR 0.18, 95% CI 0.05, 0.57), but higher in fHP (HR 1.58, 95% CI 1.01, 2.40). The extent of fibrosis also predicted FVC decline and mortality. After immunosuppression, FVC decline was slower compared with pre-treatment in NSIP (by 2.1%/year, 95% CI 1.4, 2.8), with no change for UIP or fHP. Conclusion Multiple radiologic patterns are possible in CTD-ILD, including a fHP pattern. NSIP and OP were associated with better outcomes and response to immunosuppression, while fHP had worse survival compared with UIP.

rheumatology
Vitamin D deficiency in connective tissue disease-associated interstitial lung disease.

Dongmei Huang,Junli Chen,Zhongjie Wang,Mingting Deng,L. Tang

2018-05-24

Clinical and Experimental Rheumatology

Abstract:OBJECTIVES To determine and compare the prevalence of vitamin D deficiency in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD). METHODS The level of vitamin D was determined by the serum levels of 1,25(OH)2D3. We evaluated 144 patients in our study, including 53 subjects in the CTD-ILD group and 91 subjects in the CTD group without ILD. CTD was diagnosed following the American College of Rheumatology criteria, and ILD was diagnosed by high-resolution computed tomography. Patients with other known causes of ILD and other pulmonary diseases were excluded. Vitamin D deficiency level was <20 ng/ml. This is a retrospective study. RESULTS Serum vitamin D levels were significantly lower in CTD-ILD patients (p<0.0001). Vitamin D deficiency was lower in the CTD-ILD group (mean±SD: 11.5±4.1 ng/ml) than in the control group (13.9±4.8 ng/ml, p=0.004). The CTD-ILD group was older (p=0.002), had higher levels of fibrinogen (p=0.028) and positive anti-CCP (p=0.026), faster ESR (p=0.001), lower serum levels of serum calcium (p=0.002), and more immunosuppressive therapies (p=0.011). Decreased serum albumin and higher positive antinuclear antibodies (ANA) were associated with reduced vitamin D levels in the vitamin D subgroups. When the odds ratio was adjusted for CTD-ILD, vitamin D deficiency was also a risk factor for CTD-ILD, whereas serum levels of calcium was a protective factor for CTD-ILD. CONCLUSIONS Serum vitamin D deficiency is associated with CTD-ILD and is a risk factor. Therefore, vitamin D may play a role in the pathogenesis of CTD-ILD.

Medicine
Clinical Significance of Interleukin-6, Total Bilirubin, CD3 + CD4 + T Cells Counts in the Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease: a Cross-Sectional Study

Chengxing Ma,Kaifang Meng,Shenyun Shi,Tingting Zhao,Shanshan Chen,Xuan Zhou,Ruilu Shu,Miao Ma,Mi Tian,Jingjing Ding

DOI: https://doi.org/10.1186/s40001-023-01384-0

IF: 4.981

2023-01-01

European Journal of Medical Research

Abstract:Interstitial lung disease (ILD) is a severe complication of connective tissue disease (CTD) that can significantly impact patients' prognosis and quality of life. However, the current diagnostic arena lacks reliable biomarkers for detecting and monitoring the progression and exacerbation of CTD-ILD. This study aimed to investigate the clinical value of 12 serum cytokines in the diagnosis of CTD-ILD and prediction of the risk of acute exacerbation (AE) in this disease. This study was a cross-sectional investigation. Ninety-one hospitalized CTD patients were allocated into two groups: CTD-ILD group (n = 61) and CTD-non-ILD group (n = 30), and 30 sex-age matched healthy volunteers were enrolled as controls. The serum concentrations of interferon (IFN)-α, IFN-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-17A, and IL-1β were measured by Luminex suspension arrays. Logistic regression was employed to determine the significance of variables in the occurrence of AE-CTD-ILD. A nomogram was constructed to visualize the independent variables. Elevated levels of IL-6, IL-8, and TNF-α were observed and compared in the CTD-ILD group with CTD-non-ILD (all P < 0.05). Similarly, the levels of IL-6, IL-8 and TNF-α were higher in the acute exacerbation (AE-CTD-ILD) group compared with stable CTD-ILD (S-CTD-ILD) (P < 0.001, P < 0.001, and P = 0.022). Significant correlations between serum IL-6 and PaO2/FiO2 ratio (r = − 0.463, P < 0.001), percent predicted forced vital capacity (FVC
Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis

Bon San Koo,Kyu Yong Park,Hyun Jung Lee,Hyun Jung Kim,Hyeong Sik Ahn,Shin-Young Yim,Jae-Bum Jun

DOI: https://doi.org/10.1186/s13075-021-02494-y

2021-04-06

Abstract:Abstract Background This study aimed to analyze the literature systematically to determine the clinical characteristics and prognosis of patients with connective tissue disease (CTD) with combined pulmonary fibrosis and emphysema (CPFE) compared to those of patients with CTD-interstitial lung disease (CTD-ILD) without emphysema. Methods We searched MEDLINE, EMBASE, Cochrane Library, and KoreaMed for relevant articles published before July 2019. Studies meeting all the following criteria were included: (1) original research studies evaluating the effect of CPFE on CTD, (2) studies that compared patients with CTD-CPFE to those with CTD-ILD without emphysema, and (3) studies providing data on physical capacity, pulmonary function, or death in patients with CTD. Clinical characteristics of patients with CTD-CPFE were compared with those of patients with CTD-ILD without emphysema, and the influence of CPFE on physical capacity, pulmonary function, and death was analyzed. Results Six studies between 2013 and 2019 were included. Two hundred ninety-nine (29.5%) and 715 (70.5%) patients had CTD-CPFE and CTD-ILD without emphysema, respectively. Regarding the type of CTD, 711 (68.3%) patients had systemic sclerosis, 263 (25.3%) rheumatoid arthritis, and 67 (6.4%) other CTDs. Patients with CTD-CPFE had a higher frequency of pulmonary hypertension and pulmonary fibrosis > 20% of the total lung volume, higher ratio of the forced vital capacity to the diffusion capacity of the lung for carbon monoxide (DLCO), lower arterial oxygen pressure at rest, and lower DLCO compared to those in patients with CTD-ILD without emphysema. In addition, more deaths occurred among those with CTD-CPFE (odds ratio, 2.95; 95% confidence interval, 1.75–4.96). Conclusion CTD-CPFE is associated with worse physical and pulmonary function and more deaths compared to those in CTD-ILD without emphysema. These findings indicate the need for increased awareness and close monitoring of patients with CTD-CPFE.

rheumatology
[Analysis for clinical features of cardiovascular complication of diffuse connective tissue disease].

Xiao-li Deng,Xiang-yuan Liu,Jin-xia Zhao

DOI: https://doi.org/10.3969/j.issn.1671-167x.2010.02.006

2010-01-01

Abstract:OBJECTIVE:To analyze the clinical features and prognosis of cardiovascular complications of diffuse connective tissue disease(dCTD). METHODS:Clinical data of cardiovascular complications of 181 cases of dCTD were retrospectively analyzed. Clinical data of two subsets [rheumatoid arthritis (RA, 81) and systemic lupus erythematosus (SLE, 42)] were also analyzed. Follow-up was carried out for all the patients. RESULTS:RA and SLE were the most common disease complicated by cardiovascular disease needing hospitalization. The most frequent cardiovascular complications in dCTD patients were hypertension, hyperlipidemia and coronary artery disease. The most common echocardiographic abnormalities were valvular regurgitation, left ventricular diastolic dysfunction, enlargement of left atrium, pulmonary hypertension and pericardial effusion (57.8%, 50.6%, 33.7%, 21.7% and 19.3%, respectively). Compared with the subset of RA, patients were younger at onset of hypertension, coronary artery disease and hyperlipidemia in the subset of SLE [(40+/-11) vs (56+/-15), P<0.001; (53+/-12) vs (64+/-10), P=0.011; (44+/-16) vs (58+/-12), P=0.012, respectively]. Both pericardial effusion (P<0.001) and enlargement of left ventricle (P=0.03) were more frequent, and left ventricular diastolic dysfunction was less common (P<0.001). Median survival time of these dCTD patients was 9.8 years. CONCLUSION:RA and SLE are the most common diffuse connective tissue diseases complicated by cardiovascular disease needing hospitalization. The most frequent cardiovascular complications in dCTD patients are hypertension, hyperlipidemia and coronary artery disease. The prognosis of dCTD patients complicated with cardiovascular diseases is poor. SLE patients are younger at onset of cardiovascular diseases.
Activity against plant pathogenic fungi of phomalactone isolated from Nigrospora sphaerica.

Jin-Cheol Kim,G. Choi,Joonghyeop Park,Heung Tae Kim,Kwang Yun Cho

DOI: https://doi.org/10.1002/PS.318

IF: 4.462

2001-06-01

Pest Management Science

Abstract:Phomalactone, 5,6-dihydro-5-hydroxy-6-prop-2-enyl-2H-pyran-2-one, produced by the fungus Nigrospora sphaerica, was tested in vitro against nine plant pathogenic fungi, and specifically inhibited the mycelial growth of Phytophthora infestans, with an MIC value of 2.5 mg litre-1. Its inhibitory activities against sporangium and zoospore germination of P infestans were similar to those against Phytophthora capsici. In vivo, at 100 and 500 mg litre-1, it reduced the development of tomato late blight caused by P infestans.
Association between the cardiothoracic ratio on chest X-rays and the respiratory function in patients with interstitial lung diseases: A cross-sectional study

Akihiko Hagiwara,Izumi Yamatani,Ryohei Kudoh,Kazufumi Hiramatsu,Jun-Ichi Kadota,Kosaku Komiya

DOI: https://doi.org/10.2169/internalmedicine.4104-24

2024-08-28

Abstract:Objective Patients with advanced interstitial lung disease (ILD) struggle to undergo spirometry to evaluate the respiratory function. The cardiothoracic ratio (CTR) on chest radiography can potentially reflect the lung volume; however, this has not yet been fully established. This study aimed to clarify the relationship between the CTR and the respiratory function in patients with interstitial lung diseases. Patients and Methods We reviewed 120 consecutive patients with idiopathic interstitial lung disease who were admitted to our department between April 2018 and March 2023 and who underwent chest radiography, spirometry, and echocardiography. A multiple linear regression analysis was used to identify the factors associated with the CTR. Correlations between the CTR and the respiratory or cardiac function were assessed using Pearson's correlation coefficient. Results A multiple linear regression analysis showed the percent vital capacity (β = -0.598, p <0.001), age (β = 0.405, p <0.001), and female sex (β = 0.177, p = 0.047) to be independently associated with the CTR, whereas no relationship was observed between the left ventricular ejection fraction, body mass index, and smoking habits. The CTR was significantly negatively correlated with the vital capacity (r = -0.490, p <0.001). Conclusions An increased CTR might reflect a decreased vital capacity, but not a decreased cardiac function, in patients with interstitial lung diseases. Measuring the CTR can thus be beneficial for predicting progression in patients with ILD.
Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?

Patricia Richter,Anca Cardoneanu,Nicoleta Dima,Ioana Bratoiu,Ciprian Rezus,Alexandra Maria Burlui,Damiana Costin,Luana Andreea Macovei,Elena Rezus

DOI: https://doi.org/10.3390/ijms24119388

IF: 5.6

2023-05-28

International Journal of Molecular Sciences

Abstract:Interstitial lung disease (ILD) is a severe and frequent manifestation of connective tissue diseases (CTD). Due to its debilitating potential, it requires serious evaluation and treatment. The prevalence of ILD in systemic lupus erythematosus (SLE) is still controversial. Therefore, in order to establish the diagnosis of ILD, an overlap syndrome must be excluded. Increasing the identification of SLE-associated ILD cases should become a target. To treat this complication, various therapies are now being proposed. To date, no placebo-controlled studies were conducted. Regarding another CTD, systemic sclerosis (SSc), SSc-associated ILD is considered one of the leading causes of mortality. The incidence of ILD varies among disease subtypes, being influenced by diagnostic method, but also by disease duration. Due to the high prevalence of this complication, all SSc patients should be investigated for ILD at the time of SSc diagnosis and during the course of the disease. Fortunately, progress was made in terms of treatment. Nintedanib, a tyrosine kinases inhibitor, showed promising results. It appeared to decrease the rate of progression of ILD compared to placebo. This review aimed to provide up-to-date findings related to SLE-associated ILD and SSc-associated ILD, in order to raise awareness of their diagnosis and management.

biochemistry & molecular biology,chemistry, multidisciplinary

Strahlentherapie nach brusterhaltender Operation beim Mammakarzinom

Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis

Clinical manifestations of connective tissue diseases complicated with interstitial lung disease:an analysis of 90 cases

E012 Burden and risk factors for cardiovascular involvement in connective tissue disease

Analysis of Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 161 Patients: A Retrospective Study

Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE

The impact of hospitalization on mortality in patients with connective tissue disease-associated interstitial lung disease: a medical records review study

Synergism of X irradiation and radiographic contrast medium.

Characteristics and Survival of Connective Tissue Disease Associated Pulmonary Arterial Hypertension Patients with and Without Interstitial Lung Disease

Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease

Comparative analysis of connective tissue disease–associated interstitial lung disease and interstitial pneumonia with autoimmune features

Microvascular alterations of the ocular surface and retina in connective tissue disease-related interstitial lung disease

Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study

Lung imaging patterns in connective tissue disease–associated interstitial lung disease impact prognosis and immunosuppression response

Vitamin D deficiency in connective tissue disease-associated interstitial lung disease.

Clinical Significance of Interleukin-6, Total Bilirubin, CD3 + CD4 + T Cells Counts in the Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease: a Cross-Sectional Study

Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis

[Analysis for clinical features of cardiovascular complication of diffuse connective tissue disease].

Activity against plant pathogenic fungi of phomalactone isolated from Nigrospora sphaerica.

Association between the cardiothoracic ratio on chest X-rays and the respiratory function in patients with interstitial lung diseases: A cross-sectional study

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?